Filing Details

Accession Number:
0001179110-11-012720
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-29 16:14:52
Reporting Period:
2011-08-26
Filing Date:
2011-08-29
Accepted Time:
2011-08-29 16:14:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
884629 Watson Pharmaceuticals Inc WPI Pharmaceutical Preparations (2834) 953872914
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1241751 A David Buchen Morris Corporate Center Iii
400 Interpace Pkwy
Parsippany NJ 07054
Exec Vp,General Counsel & Sec. No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0033 Acquisiton 2011-08-26 17,499 $28.15 84,071 No 4 M Direct
Common Stock, Par Value $0.0033 Acquisiton 2011-08-26 1 $28.15 84,072 No 4 M Direct
Common Stock, Par Value $0.0033 Disposition 2011-08-26 17,500 $65.50 66,572 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock, Par Value $0.0033 Non-Qualified Options to Purchase Common Stock Disposition 2011-08-26 17,499 $0.00 17,499 $28.15
Common Stock, Par Value $0.0033 Incentive Stock Options to Purchase Common Stock Disposition 2011-08-26 1 $0.00 1 $28.15
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2004-11-26 2011-11-26 No 4 M Direct
0 2004-11-26 2011-11-26 No 4 M Direct
Footnotes
  1. Includes shares of restricted stock issued pursuant to the Fourth Amendment and Restatement of the 2001 Incentive Award Plan of Watson Pharmaceuticals, Inc.